BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Biologics

MOLCURE and Boehringer Ingelheim Forge AI-Powered Alliance to Accelerate Antibody Drug Discovery

MOLCURE Inc. announced that it has entered into a multi-year strategic research agreement with Boehringer Ingelheim for the discovery of innovative an...

October 08, 2025 | News

Wasatch BioLabs Expands Long-Read Sequencing Portfolio with Oxford Nanopore Research Assays

Wasatch BioLabs (WBL), a Renew Biotechnologies subsidiary, and the largest U.S. sequencing service provider dedicated exclusively to long-read se...

October 07, 2025 | News

RoosterBio and Secretome Therapeutics Achieve Commercial-Scale Production Milestone for Lead Cell Therapy STM-01

RoosterBio Inc., a leading supplier of human mesenchymal stem/stromal cells (MSCs), highly engineered media, and bioprocess development services, and...

October 07, 2025 | News

Lonza Expands GMP Portfolio with TheraPEAK® AmpliCell® Cytokines and 293-GT® Medium for Enhanced Cell and Gene Therapy Manufacturing

AmpliCell® Cytokines enable cell expansion optimization, batch-to-batch consistency and easy transition from research to manufacturing TheraPEAK&r...

October 07, 2025 | News

Turning Signals into Cures: The Big Data Blueprint for Cell Therapy Factories

Cell therapy manufacturing is entering a data-driven era, as the industry grapples with complex production processes, high costs, and the need for personal...

October 07, 2025 | Analysis

JCR Pharmaceuticals Grants Menagen Exclusive Rights to Commercialise Fabry Therapy Across MENAT Region

JCR Pharmaceuticals Co., Ltd. a global specialty biopharmaceutical company dedicated to developing therapies for rare and genetic diseases, announced ...

October 03, 2025 | News

Gene Solutions and AMPATH Partner to Launch Advanced Genomics Laboratory

Gene Solutions, a leading genetic testing innovator in Asia, has partnered with AMPATH (American Institute of Pathology and Laboratory ...

October 02, 2025 | News

Cell Therapies and Teijin Forge Strategic MoU to Build Asia-Pacific Cell and Gene Therapy Infrastructure

Cell Therapies Pty Ltd. (“Cell Therapies”) and Teijin Limited announced that they have signed a Memorandum of Unders...

October 02, 2025 | News

Made Scientific and Syenex Forge Partnership to Transform T Cell Therapy Manufacturing

Made Scientific, a leading cell therapy contract development and manufacturing organization (CDMO) and Syenex, a synthetic biology company specializing in ...

October 01, 2025 | News

Japan Grants Orphan Drug Designation to JR-446 for Sanfilippo Syndrome Type B

MEDIPAL HOLDINGS CORPORATION and JCR Pharmaceuticals Co., Ltd. announced that the Ministry of Health, Labour and Welfare of Japa...

October 01, 2025 | News

PromoCell Enters GMP Market with Custom Cell Culture Media Services for Clinical Applications

PromoCell GmbH, a leading global manufacturer of primary human cells and specialized cell culture media for biomedical research, announces its entry into t...

October 01, 2025 | News

Full-Life Technologies Secures US$77 Million in Series C and Debt Financing to Advance Global Radiopharmaceutical Pipeline

Series C led by Junson Capital along with new investor syndicate and existing shareholders Funding will further advance Full-Life's global radiopharmace...

September 30, 2025 | News

WuXi XDC Co-Hosts 2025 BPD Singapore Summit Showcasing Innovation in Bioconjugates and Global Biopharma Collaboration

The 2025 BPD (Biopharmaceutical Bioprocess Development) Singapore Summit, which co-hosted by WuXi XDC (Stock Code: 2268.HK), was successfully conclude...

September 30, 2025 | News

Health Hope Pharma and Hanmi Grant Gilead Global Rights to Encequidar in Virology

Health Hope Pharma Limited announced that it has entered into a global licensing and collaboration agreement with Gilead Sciences, Inc. ("Gilead") for ence...

September 30, 2025 | News

Stay Connected